![]() |
FAQ | Contact Us | Blog | Partners | News & Events |

Home Page / Contract Research ...
Higher throughput, better data, rapid turn-around times.
BIOCIUS provides custom assay development and screening services utilizing proprietary RapidFire technology. In-house experienced scientists have screened millions of wells for our pharma and biotech clients in support of their drug discovery efforts.
The RapidFire label-free technology used for these studies is amenable to a host of compounds and targets including those which are difficult or impossible to screen using traditional optical technologies. Very fast turn-around times enable important decisions on pharmaceutical compounds earlier in the drug discovery process. Please contact us to discuss your application (+1 781 928 2700).
BIOCIUS offers both lead discovery and in vitro ADME screening services.
| High-throughput Screening Assays | In vitro ADME Assays |
|
|
BIOCIUS. Faster Answers.
RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,